Apiam Shareholders Back Adamantem Takeover in Overwhelming Vote

Claim 50% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potentialApiam Animal Health Ltd. ( (AU:AHX) ) has issued an update. Apiam Animal Health shareholders have overwhelmingly approved the proposed acquisition of the company by Adamantem Capital’s controlled entities, Pepper Bidco and Pepper Holdco, via a scheme of arrangement. With 99.94% of votes cast and 95.76% of voting shareholders in favour, the deal has cleared the key shareholder hurdle and now awaits final court approval and satisfaction of remaining conditions, after which Apiam shares are expected to be suspended and the scheme implemented later in February 2026, marking a transition to private ownership that will reshape the company’s capital structure and governance for existing investors and other stakeholders. The most recent analyst rating on (AU:AHX) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Apiam Animal Health Ltd. stock, see the AU:AHX Stock Forecast page. More about Apiam Animal Health Ltd. Apiam Animal Health Limited is one of Australia’s leading rural veterinary businesses, operating more than 80 veterinary clinic sites and ancillary business locations across regional and peri-urban areas nationwide. The company employs over 1,000 staff, including a large team of experienced veterinarians and allied professionals, and focuses on providing best-in-class care through its companion animal, production animal and allied veterinary services to clients, animals and local communities. Average Trading Volume: 251,994 Technical Sentiment Signal: Buy Current Market Cap: A$161M For a thorough assessment of AHX stock, go to TipRanks’ Stock Analysis page.